RE: The two questions the current board have to answer22 Dec 2020 10:51
Corporate Developments
P2F is adding resources across production and sales in order to meet the challenges of establishing new production and developing the sales pipeline. However the cash-flow consequence of the delays set out above, primarily a reduction of sales revenue in the near term, is that P2F's working capital requirements in order to build sales at P2F are now greater than previously anticipated and the board is considering how best to fund this additional requirement. As at 10(th) December 2020 the Company had cash of GBP706.5k and no debt save for trade creditors.
The Company looks forward to providing further updates as it seeks to develop its business in this emerging and exciting business.
- ENDS -
ENQUIRIES :
Remote Monitored Systems plc
John Richardson (Executive Director) +44 7751 118916
Gareth Cave (MD Pharm2Farm)
SP Angel Corporate Finance LLP +44 20 3470 0470
Nominated Adviser and Joint Broker
Stuart Gledhill
Caroline Rowe
Peterhouse Corporate Finance +44 20 7469 0930
Joint Broker